85 related articles for article (PubMed ID: 2441410)
21. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
22. [Humoral factors in cardiogenic shock].
Kölbel F; Veselý P
Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
[No Abstract] [Full Text] [Related]
23. [Evaluation of the effectiveness of methylprednisolone sodium succinate in reducing the infarct area].
Tartagni F; Melandri G; Maresta A; Magnani B
Boll Soc Ital Cardiol; 1981; 26(10):939-48. PubMed ID: 6758813
[No Abstract] [Full Text] [Related]
24. [Effects of aprotinin on TNF-alpha levels after cardiopulmonary bypass].
Liu LM; Hu JG; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):166-8. PubMed ID: 12212211
[TBL] [Abstract][Full Text] [Related]
25. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
26. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients?
Schmartz D; Tabardel Y; Preiser JC; Barvais L; d'Hollander A; Duchateau J; Vincent JL
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):184-90. PubMed ID: 12539003
[TBL] [Abstract][Full Text] [Related]
27. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
28. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
[No Abstract] [Full Text] [Related]
29. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
30. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
[TBL] [Abstract][Full Text] [Related]
31. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
[TBL] [Abstract][Full Text] [Related]
32. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
33. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
[TBL] [Abstract][Full Text] [Related]
34. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
[TBL] [Abstract][Full Text] [Related]
35. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
[TBL] [Abstract][Full Text] [Related]
36. Myocardial dysfunction in endotoxin- and E. coli-induced shock: pathophysiological mechanisms.
Archer LT
Circ Shock; 1985; 15(4):261-80. PubMed ID: 3888434
[TBL] [Abstract][Full Text] [Related]
37. [The role of the myocardial depressant factor in the pathogenesis of the shock].
Pagni E
Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
[TBL] [Abstract][Full Text] [Related]
38. Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass.
Van Norman GA; Patel MA; Chandler W; Vocelka C
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):253-6. PubMed ID: 10890475
[TBL] [Abstract][Full Text] [Related]
39. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I.
Whitlock RP; Young E; Noora J; Farrokhyar F; Blackall M; Teoh KH
J Surg Res; 2006 May; 132(2):188-94. PubMed ID: 16566943
[TBL] [Abstract][Full Text] [Related]
40. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
